Generic Medicine Info
May be taken with or without food.
Stenosing peptic ulcer or pyloroduodenal obstruction. Premature infants and neonates. Lactation. Concomitant use with other antihistamine-containing medicines (including topical antihistamines).
Special Precautions
Patient with narrow-angle glaucoma, prostatic hypertrophy or genitourinary obstruction, urinary retention, asthma, bronchitis, COPD, CV (e.g. hypertension, ischaemic heart disease), thyroid disorder, myasthenia gravis, seizure disorders (e.g. epilepsy). Moderate to severe renal and hepatic impairment. Elderly. Pregnancy. Patient Counselling This drug may cause drowsiness or sedation, dizziness, blurred vision, cognitive and psychomotor impairment, if affected, do not drive or operate machinery. Monitoring Parameters Monitor mental alertness.
Adverse Reactions
Significant: Drug tolerance (continuous use). Rarely, eczematous reactions (topical). Blood and lymphatic system disorders: Haemolytic anaemia, thrombocytopenia, agranulocytosis. Cardiac disorders: Palpitations, tachycardia, extrasystoles. Gastrointestinal disorders: Dry mouth, epigastric distress, nausea, vomiting, diarrhoea, constipation. General disorders and administration site conditions: Fatigue. Metabolism and nutrition disorders: Anorexia. Nervous system disorders: Sedation, drowsiness, restlessness, dizziness, excitability (children), headache. Psychiatric disorders: Disturbance in attention, confusion, nervousness. Renal and urinary disorders: Urinary frequency, urinary retention, difficulty in micturition. Respiratory, thoracic and mediastinal disorders: Thickening of bronchial secretions. Skin and subcutaneous tissue disorders: Sensitisation reaction, photosensitivity. Vascular disorders: Hypotension.
Drug Interactions
May increase sedative effects of other CNS depressants (e.g. tranquilizers, hypnotics, anxiolytics). Enhanced and prolonged anticholinergic effects with MAOIs. May potentiate effects of anticholinergic agents (e.g. atropine, TCA). May diminish therapeutic effect of betahistine.
CIMS Class
Antihistamines & Antiallergics / Antiparkinsonian Drugs / Antivertigo Drugs / Hypnotics & Sedatives
ATC Classification
D04AA32 - diphenhydramine ; Belongs to the class of topical antihistamines used in the treatment of pruritus.
R06AA02 - diphenhydramine ; Belongs to the class of aminoalkyl ethers used as systemic antihistamines.
Disclaimer: This information is independently developed by CIMS based on diphenhydramine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2023 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in